Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-08-002273
Filing Date
2008-02-28
Accepted
2008-02-28 16:53:42
Documents
13
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K y50463e10vk.htm 10-K 1013393
2 EX-10.39: LETTER AGREEMENT y50463exv10w39.htm EX-10.39 6598
3 EX-10.55: CHANGE IN CONTROL AGREEMENT y50463exv10w55.htm EX-10.55 5982
4 EX-10.56: CONSULTING AGREEMENT y50463exv10w56.htm EX-10.56 25071
5 EX-10.57: CONSULTING AGREEMENT y50463exv10w57.htm EX-10.57 31305
6 EX-10.61: COMPENSATORY ARRANGEMENTS FOR NON-EMPLOYEE DIRECTORS y50463exv10w61.htm EX-10.61 14272
7 EX-10.62: COMPENSATORY ARRANGEMENTS OF EXECUTIVE OFFICERS y50463exv10w62.htm EX-10.62 12504
8 EX-21: SUBSIDIARIES y50463exv21.htm EX-21 1057
9 EX-23: CONSENT OF KPMG LLP y50463exv23.htm EX-23 3284
10 EX-31.1: CERTIFICATION y50463exv31w1.htm EX-31.1 6165
11 EX-31.2: CERTIFICATION y50463exv31w2.htm EX-31.2 6252
12 EX-32.1: CERTIFICATION y50463exv32w1.htm EX-32.1 2836
13 EX-32.2: CERTIFICATION y50463exv32w2.htm EX-32.2 2954
  Complete submission text file 0000950123-08-002273.txt   1133162
Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-15190 | Film No.: 08651336
SIC: 2835 In Vitro & In Vivo Diagnostic Substances